|
|||
2010-02-04 06:00:00 CET 2010-02-04 06:02:03 CET REGULATED INFORMATION Össur hf. - Financial Statement ReleaseÖssur - Full year results 2009AnnouncementÖssur hf. No. 3/2010 Reykjavik, 4 February 2010 SOLID OPERATIONS - 2009 Highlights: * Sales USD331 million * Gradual increase in sales during the year * EBITDAmargin 20% * Strong performance in Prosthetics * Second generation of Bionics launched * Enhanced sales platform in place * Listing on NASDAQ OMX Copenhagen Guidance 2010: * Sales 3-4% LCY growth * EBITDA 8-10% LCY growth Jon Sigurdsson, President & CEO, comments:"The results for 2009 are good and show clearly the Company's strength. During the year we have seen the global economic turmoil having an impact on our customers and affecting some of our markets. However, Össur continues to beprofitable and operations are sound. Our Bionic product line has gained further momentum through the launch of the second generation of the RHEO KNEE as well as the acceptance of the PROPRIO FOOT into the US reimbursement systems. In 2009 we have invested significantly in aligning our B&S business to take advantage of the prevailing market opportunity. We believe that 2010 will be an exciting year for Össur." Össur Investor Meeting Thursday 4 February in Copenhagen - Live webcast at 12:00 CET/ 11:00 GMT/ 6:00 EST Thursday 4 February 2010Jon Sigurdsson, President and CEO, and Hjorleifur Palsson, CFO, will host a meeting for investors, analysts and shareholders presenting and discussing the results of the fourth quarter and the year 2009. The meeting will be held in Copenhagen at the Radisson Blu Royal Hotel, Hammerichsgade 1, Copenhagen. The meeting will be conducted in English. There will be a live broadcast from the meeting on the Össur website:www.ossur.com/investors <http://www.ossur.com/investors> To participate in the meeting please call one of the following telephone numbers: Europe:+ 44 (0) 207 509 5139 The United States: +1 718 354 1226 Iceland:800 9313 [HUG#1380514] |
|||
|